Are lamotrigine kinetics altered in menopause? Observations from a drug monitoring database

Epilepsy and Behavior

Volumn 19, Issue 1, 2010, Pages 86-88

  Tomson, Torbjörn ^a   Lukic, Stevo ^b   Öhman, Inger ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF NI   (Serbia)

Author keywords

Carbamazepine; Epilepsy; Lamotrigine; Menopause; Pharmacokinetics; Therapeutic drug monitoring

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE;

ADULT; ARTICLE; DATA BASE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG MONITORING; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; SEX DIFFERENCE; SWEDEN;

ANTICONVULSANTS; CONFIDENCE INTERVALS; DATABASES, FACTUAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; EPILEPSY; FEMALE; HUMANS; MALE; MENOPAUSE; RETROSPECTIVE STUDIES; TRIAZINES;

EID: 77956615896     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2010.06.047     Document Type: Article

References (11)

1. Beck O., Öhman I., Nordgren H. Determination of lamotrigine and its metabolites in human plasma by liquid chromatography-mass spectrometry. Ther. Drug Monit. 2006, 28:603-607.
2. Battino D., Croci D., Granata T., Estienne M., Pisani F., Avanzini G. Lamotrigine plasma concentrations in children and adults: influence of age and associated therapy. Ther. Drug Monit. 1997, 19:620-627.
3. Hussein Z., Posner J. Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data. Br. J. Clin. Pharmacol. 1997, 43:457-465.
4. Grasela T.H., Fiedler-Kelly J., Cox E., Womble G.P., Risner M.E., Chen C. Population pharmacokinetics of lamotrigine adjunctive therapy in adults with epilepsy. J. Clin. Pharmacol. 1999, 39:373-384.
5. Chan V., Morris R.G., Ilett K.F., Tett S.E. Population pharmacokinetics of lamotrigine. Ther. Drug Monit. 2001, 23:630-635.
6. Pennell P.B., Newport D.J., Stowe Z.N., et al. The impact of pregnancy and childbirth on the metabolism of lamotrigine. Neurology 2004, 62:292-295.
7. Öhman I., Beck O., Vitols S., Tomson T. Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy. Epilepsia 2008, 49:1075-1080.
8. Sabers A., Öhman I., Christensen J., Tomson T. Oral contraceptives reduce lamotrigine plasma levels. Neurology 2003, 61:570-571.
9. Harden C.L., Herzog A.G., Nikolov B.G., et al. Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study. Epilepsia 2006, 47:1447-1451.
10. Öhman I., Luef G., Tomson T. Effects of pregnancy and contraception on lamotrigine disposition: new insights through analysis of lamotrigine metabolites. Seizure 2008, 17:199-202.
11. Wegner I., Edelbroek P.M., Bulk S., Lindhout D. Lamotrigine kinetics within the menstrual cycle, after menopause, and with oral contraceptives. Neurology 2009, 73:1388-1393.